333D partners with BioScan 360 to bring blockchain innovation to preventative healthcare

• Partnership with BioScan 360 to deliver full-body MRI preventative healthcare services
• Patients’ MRI data to be stored on blockchain for secure, auditable ownership
• Global preventative health market projected to reach US$585 billion by 2030

Special Report: 333D Limited has entered a pilot collaboration with BioScan 360 to provide full-body MRI preventative healthcare services, marking the company’s entry into one of the fastest-growing sectors of global health.

Under the agreement, patients will undergo full-body MRI scans through BioScan 360 while 333D (ASX:T3D) records critical imaging and clinical data on the blockchain.

This ensures decentralised, tamper-proof storage of sensitive medical records and gives ownership of that data back to the patient – a major shift from traditional centralised hospital databases

T3D will manage the marketing, digital asset management and patient-facing record system, collecting service fees directly.

Each scan is expected to generate revenue between $2,500 and $4,000, with BioScan 360 receiving a facility fee per scan.

Preventative health meets digital innovation

Full-body MRI is increasingly used as a preventative tool for early detection of cancers, cardiovascular conditions and neurological disorders – without the use of radiation.

Global demand for preventative diagnostics is accelerating, driven by longevity trends, patient awareness and personalised medicine.

The global preventative healthcare tech and services market, valued at US$243 billion in 2022, is forecast to grow to US$585 billion by 2030 at a compound annual rate of 11.8%

333D believes this collaboration positions the company at the intersection of digital health, blockchain technology and preventative medicine – areas with scalable global potential.

Patient empowerment through blockchain

By recording MRI data on the blockchain, patients can securely store and control their medical information. This provides several key benefits:

• Data ownership and control – records are patient-held and auditable.
• Privacy and security – decentralised storage protects against data breaches.
• Portability – records can be shared instantly with authorised clinicians.
• Continuity of care – a verified history of imaging data enables longitudinal monitoring.

This longitudinal imaging capability means subtle health changes can be detected earlier, improving diagnostic accuracy and personalising preventative care.

A national vision

Pending success of the pilot, 333D plans to expand the offering nationwide in collaboration with BioScan 360 and other leading healthcare institutions.

This rollout strategy would establish 333D as a pioneer in applying blockchain and artificial intelligence to medical imaging, cementing its position at the frontier of digital asset management and health technology.

“This collaboration reflects 333D’s ongoing commitment to delivering cutting-edge healthcare solutions by merging advanced medical imaging with blockchain technology,” said 333D director Dr Nigel Finch.

“By empowering patients to take control of their health data while offering both patients and medical professionals a secure and auditable platform for long-term analysis, 333D is at the forefront of the shift towards preventative and patient-centred care.”

This article was developed in collaboration with 333D Limited, a Stockhead advertiser at the time of publishing.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.